We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$67.2B
AUM Growth
-$732M
Cap. Flow
-$4.09B
Cap. Flow %
-6.1%
Top 10 Hldgs %
8.84%
Holding
4,165
New
463
Increased
1,438
Reduced
1,417
Closed
409

Sector Composition

Rank Sector Weight
1 Healthcare 12.1%
2 Communication Services 8.89%
3 Technology 8.48%
4 Energy 7.71%
5 Financials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AG icon
3626
First Majestic Silver
AG
$8.05B
$116K ﹤0.01%
35,699
-16,859
-32% -$57.3K
FBIO icon
3627
Fortress Biotech
FBIO
$111M
$114K ﹤0.01%
+2,723
New +$114K
AGI icon
3628
Alamos Gold
AGI
$12.4B
$113K ﹤0.01%
34,385
-3,300
-9% -$12K
MFIN icon
3629
Medallion Financial
MFIN
$226M
$113K ﹤0.01%
+16,040
New +$125K
SPXC icon
3630
PUT
SPX Corp
SPXC
$11B
$113K ﹤0.01%
12,100
-24,600
-67% -$267K
ASMB icon
3631
Assembly Biosciences
ASMB
$506M
$112K ﹤0.01%
+1,242
New +$135K
JMI
3632
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
$112K ﹤0.01%
17,932
-20,121
-53% -$126K
DHT icon
3633
DHT Holdings
DHT
$2.97B
$110K ﹤0.01%
13,618
-75,023
-85% -$588K
PVA
3634
DELISTED
PENN VIRGINIA CORP
PVA
$108K ﹤0.01%
361,328
+273,957
+314% +$160K
IOVA icon
3635
Iovance Biotherapeutics
IOVA
$2.23B
$107K ﹤0.01%
13,894
-3,854
-22% -$26.7K
DANG
3636
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
$103K ﹤0.01%
+14,265
New +$98.2K
CAI
3637
PUT
DELISTED
CAI International, Inc.
CAI
$101K ﹤0.01%
10,000
UNIS
3638
DELISTED
Unilife Corporation
UNIS
$101K ﹤0.01%
+20,411
New +$161K
AVH
3639
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$100K ﹤0.01%
+23,412
New +$102K
EXEL icon
3640
Exelixis
EXEL
$13.9B
$99K ﹤0.01%
+17,607
New +$98.5K
REXI
3641
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$99K ﹤0.01%
16,148
+2,100
+15% +$12.9K
OFG icon
3642
OFG Bancorp
OFG
$2.21B
$98K ﹤0.01%
13,401
-15,317
-53% -$132K
OXSQ icon
3643
Oxford Square Capital
OXSQ
$151M
$97K ﹤0.01%
+15,913
New +$104K
SID icon
3644
Companhia Siderúrgica Nacional
SID
$1.43B
$97K ﹤0.01%
99,702
-272,293
-73% -$334K
ONCT
3645
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$96K ﹤0.01%
98
UEC icon
3646
Uranium Energy
UEC
$4.71B
$95K ﹤0.01%
89,535
+42,364
+90% +$45.8K
RXII
3647
DELISTED
GALENA BIOPHARMA INC COM
RXII
$89K ﹤0.01%
60,802
+31,841
+110% +$46.6K
STCN
3648
DELISTED
Steel Connect, Inc. Common Stock
STCN
$88K ﹤0.01%
3,799
+2,264
+147% +$58.7K
PGNX
3649
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$87K ﹤0.01%
14,259
-2,041
-13% -$13.4K
WLDN icon
3650
Willdan Group
WLDN
$1.1B
$85K ﹤0.01%
+10,201
New +$102K

Similar funds

D.E. Shaw & Co's Q4 2015 Portfolio in Review

As of Q4 2015, D.E. Shaw & Co held 4,165 positions worth $67.2B, down 1.1% from $67.9B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

D.E. Shaw & Co withdrew a net $4.09B in Q4 2015, closing 409 positions and reducing 1,417 holdings. Its most notable exit was Altera Corp, an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.

Against the trend, D.E. Shaw & Co opened a new position in Alphabet (Google) Class A worth $417M.

  • D.E. Shaw & Co's largest Q4 2015 buy was Alphabet (Google) Class A: 10,723,880 shares worth $417M.
  • D.E. Shaw & Co added most to Apple in Q4 2015, an estimated $483M increase.
  • D.E. Shaw & Co's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $632M.
  • D.E. Shaw & Co fully exited Altera Corp in Q4 2015, selling an estimated $236M.
  • D.E. Shaw & Co's ten largest holdings make up 8.8% of its $67.2B portfolio in Q4 2015.
  • D.E. Shaw & Co opened 463 new positions and closed 409 in Q4 2015.
  • D.E. Shaw & Co's portfolio value fell 1.1% quarter-over-quarter to $67.2B.

Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.